
Igor Galynker
Director, International Suicide Prevention Program · Icahn School of Medicine at Mount Sinai
Credentials: · · ·
History
- Present
Mount Sinai Suicide Prevention Research Laboratory · Icahn School of Medicine at Mount Sinai
- Present
Galynker Family Center for Bipolar Disorder · Icahn School of Medicine at Mount Sinai
Psychiatry
Research
Hypofrontality and negative symptoms in major depressive disorder
Journal of Nuclear Medicine · 1998 · First of 6 authors · 187 citations
Depression and Anxiety · 2017 · First of 6 authors · 116 citations
Drug and Alcohol Dependence · 2006 · Last of 6 authors · 109 citations
- ZY
39 papers · 8 as a resident
- RR
9 papers
- MS
8 papers
- AF
7 papers

6 papers · 4 as a resident
- AN
5 papers · 3 as a resident

5 papers
- AW
4 papers
Grants
- 2019–2022
National Institute of Mental Health · R34
Contact PI · $833.3K · Icahn School of Medicine at Mount Sinai
- 1998–2004
Mmt Effects on Rcmrglc in Opiate Dependent Patients
National Institute on Drug Abuse · R01
Contact PI · $912.4K · Beth Israel Medical Ctr (New York)
Clinical trials
- 2024
Psychopharmacological Treatment of Emotional Distress
Principal investigator · Withdrawn · Phase 4
Icahn School of Medicine at Mount Sinai
- 2019–2022
Principal investigator · Completed
Icahn School of Medicine at Mount Sinai
- 2013–2014
A Single Blind Study of Cranial Electrical Stimulation in Bipolar II Disorder
Principal investigator · Completed
Beth Israel Medical Center
- 2003–2007
Six Month Trial of Lamotrigine vs. Sodium Valproate for Treatment of Mixed Mania
Principal investigator · Completed · Phase 2
Beth Israel Medical Center
